Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Current Deferred Revenue (2016)

Historic Current Deferred Revenue for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to $16826.0.

  • Microbot Medical's Current Deferred Revenue fell 8635.73% to $16826.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $16826.0, marking a year-over-year decrease of 8635.73%. This contributed to the annual value of $132338.0 for FY2015, which is N/A changed from last year.
  • Per Microbot Medical's latest filing, its Current Deferred Revenue stood at $16826.0 for Q3 2016, which was down 8635.73% from $16826.0 recorded in Q2 2016.
  • In the past 5 years, Microbot Medical's Current Deferred Revenue registered a high of $141344.0 during Q1 2016, and its lowest value of $16826.0 during Q2 2016.
  • Its 5-year average for Current Deferred Revenue is $69994.7, with a median of $67245.0 in 2013.
  • Per our database at Business Quant, Microbot Medical's Current Deferred Revenue soared by 11424.96% in 2014 and then plummeted by 8635.73% in 2016.
  • Quarter analysis of 5 years shows Microbot Medical's Current Deferred Revenue stood at $74426.0 in 2012, then decreased by 9.65% to $67245.0 in 2013, then rose by 27.78% to $85925.0 in 2014, then soared by 54.02% to $132338.0 in 2015, then crashed by 87.29% to $16826.0 in 2016.
  • Its Current Deferred Revenue stands at $16826.0 for Q3 2016, versus $16826.0 for Q2 2016 and $141344.0 for Q1 2016.